Suppr超能文献

血清素能药物在细胞进入途径的不同阶段抑制基孔肯雅病毒感染。

Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

机构信息

Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

出版信息

J Virol. 2020 Jun 16;94(13). doi: 10.1128/JVI.00274-20.

Abstract

Chikungunya virus (CHIKV) is an important reemerging human pathogen transmitted by mosquitoes. The virus causes an acute febrile illness, chikungunya fever, which is characterized by headache, rash, and debilitating (poly)arthralgia that can reside for months to years after infection. Currently, effective antiviral therapies and vaccines are lacking. Due to the high morbidity and economic burden in the countries affected by CHIKV, there is a strong need for new strategies to inhibit CHIKV replication. The serotonergic drug 5-nonyloxytryptamine (5-NT) was previously identified as a potential host-directed inhibitor for CHIKV infection. In this study, we determined the mechanism of action by which the serotonin receptor agonist 5-NT controls CHIKV infection. Using time-of-addition and entry bypass assays, we found that 5-NT predominantly inhibits CHIKV in the early phases of the replication cycle, at a step prior to RNA translation and genome replication. Intriguingly, however, no effect was seen during virus-cell binding, internalization, membrane fusion and genomic RNA (gRNA) release into the cell cytosol. In addition, we show that the serotonin receptor antagonist methiothepin mesylate (MM) also has antiviral properties toward CHIKV and specifically interferes with the cell entry process and/or membrane fusion. Taken together, pharmacological targeting of 5-HT receptors may represent a potent way to limit viral spread and disease severity. The rapid spread of mosquito-borne viral diseases in humans puts a huge economic burden on developing countries. For many of these infections, including those caused by chikungunya virus (CHIKV), there are no specific treatment possibilities to alleviate disease symptoms. Understanding the virus-host interactions that are involved in the viral replication cycle is imperative for the rational design of therapeutic strategies. In this study, we discovered an antiviral compound, elucidated its mechanism of action, and propose serotonergic drugs as potential host-directed antivirals for CHIKV.

摘要

基孔肯雅病毒(CHIKV)是一种通过蚊子传播的重要的新兴人类病原体。该病毒引起急性发热疾病,即基孔肯雅热,其特征为头痛、皮疹和使人虚弱的(多)关节炎,感染后可持续数月至数年。目前,尚无有效的抗病毒疗法和疫苗。由于受 CHIKV 影响的国家发病率和经济负担高,因此强烈需要新的策略来抑制 CHIKV 复制。血清素能药物 5-壬氧基色胺(5-NT)先前被鉴定为抑制 CHIKV 感染的潜在宿主定向抑制剂。在这项研究中,我们确定了血清素受体激动剂 5-NT 控制 CHIKV 感染的作用机制。通过时间添加和进入旁路测定,我们发现 5-NT 主要在复制周期的早期阶段抑制 CHIKV,即在 RNA 翻译和基因组复制之前的步骤。然而,有趣的是,在病毒-细胞结合、内化、膜融合和基因组 RNA(gRNA)释放到细胞质中时,没有观察到作用。此外,我们表明,血清素受体拮抗剂甲硫哒嗪甲磺酸盐(MM)也对 CHIKV 具有抗病毒特性,并且特异性干扰细胞进入过程和/或膜融合。总之,对 5-HT 受体的药理学靶向可能是限制病毒传播和疾病严重程度的有效方法。蚊媒病毒病在人类中的迅速传播给发展中国家带来了巨大的经济负担。对于许多此类感染,包括基孔肯雅病毒(CHIKV)引起的感染,没有特定的治疗方法可以缓解疾病症状。了解病毒-宿主相互作用在病毒复制周期中是必不可少的,这对于合理设计治疗策略至关重要。在这项研究中,我们发现了一种抗病毒化合物,阐明了其作用机制,并提出了血清素能药物作为 CHIKV 的潜在宿主定向抗病毒药物。

相似文献

2
Antagonism of the Sodium-Potassium ATPase Impairs Chikungunya Virus Infection.
mBio. 2016 May 24;7(3):e00693-16. doi: 10.1128/mBio.00693-16.
3
4'-Fluorouridine inhibits alphavirus replication and infection and .
mBio. 2024 Jun 12;15(6):e0042024. doi: 10.1128/mbio.00420-24. Epub 2024 May 3.
4
Explorations on the antiviral potential of zinc and magnesium salts against chikungunya virus: implications for therapeutics.
Front Cell Infect Microbiol. 2024 Jun 4;14:1335189. doi: 10.3389/fcimb.2024.1335189. eCollection 2024.
7
Deciphering the potential of baicalin as an antiviral agent for Chikungunya virus infection.
Antiviral Res. 2018 Feb;150:101-111. doi: 10.1016/j.antiviral.2017.12.012. Epub 2017 Dec 19.
8
Serotonin Receptor Agonist 5-Nonyloxytryptamine Alters the Kinetics of Reovirus Cell Entry.
J Virol. 2015 Sep;89(17):8701-12. doi: 10.1128/JVI.00739-15. Epub 2015 Jun 24.
9
A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization.
J Virol. 2014 Mar;88(5):2385-97. doi: 10.1128/JVI.03116-13. Epub 2013 Dec 26.
10
Antiviral activity of nobiletin against chikungunya virus in vitro.
Antivir Ther. 2017;22(8):689-697. doi: 10.3851/IMP3167.

引用本文的文献

2
Recent Advances in the Role of Different Nanoparticles in the Various Biosensors for the Detection of the Chikungunya Virus.
Mol Biotechnol. 2025 Jan;67(1):54-79. doi: 10.1007/s12033-024-01052-6. Epub 2024 Feb 23.
3
Selective serotonin reuptake inhibitor (SSRI) antidepressants reduce COVID-19 infection: prospects for use.
Eur J Clin Pharmacol. 2022 Oct;78(10):1601-1611. doi: 10.1007/s00228-022-03372-5. Epub 2022 Aug 9.
4
Metabolites with SARS-CoV-2 Inhibitory Activity Identified from Human Microbiome Commensals.
mSphere. 2021 Dec 22;6(6):e0071121. doi: 10.1128/mSphere.00711-21. Epub 2021 Dec 1.
5
Antivirals against the Chikungunya Virus.
Viruses. 2021 Jul 5;13(7):1307. doi: 10.3390/v13071307.
7
Drug repurposing of selective serotonin reuptake inhibitors: Could these drugs help fight COVID-19 and save lives?
J Clin Neurosci. 2021 Jun;88:163-172. doi: 10.1016/j.jocn.2021.03.010. Epub 2021 Mar 19.
8
Can selective serotonin reuptake inhibitors have a neuroprotective effect during COVID-19?
Eur J Pharmacol. 2020 Dec 15;889:173629. doi: 10.1016/j.ejphar.2020.173629. Epub 2020 Oct 3.
9
Antiviral Strategies against Arthritogenic Alphaviruses.
Microorganisms. 2020 Sep 7;8(9):1365. doi: 10.3390/microorganisms8091365.
10
Chikungunya virus requires an intact microtubule network for efficient viral genome delivery.
PLoS Negl Trop Dis. 2020 Aug 7;14(8):e0008469. doi: 10.1371/journal.pntd.0008469. eCollection 2020 Aug.

本文引用的文献

1
Chikungunya virus requires an intact microtubule network for efficient viral genome delivery.
PLoS Negl Trop Dis. 2020 Aug 7;14(8):e0008469. doi: 10.1371/journal.pntd.0008469. eCollection 2020 Aug.
2
Genetic and Functional Dissection of the Role of Individual 5-HT Receptors as Entry Receptors for JC Polyomavirus.
Cell Rep. 2019 May 14;27(7):1960-1966.e6. doi: 10.1016/j.celrep.2019.04.067.
3
JC Polyomavirus Entry by Clathrin-Mediated Endocytosis Is Driven by β-Arrestin.
J Virol. 2019 Apr 3;93(8). doi: 10.1128/JVI.01948-18. Print 2019 Apr 15.
4
Live-Cell Imaging of Early Steps of Single HIV-1 Infection.
Viruses. 2018 May 19;10(5):275. doi: 10.3390/v10050275.
5
Mxra8 is a receptor for multiple arthritogenic alphaviruses.
Nature. 2018 May;557(7706):570-574. doi: 10.1038/s41586-018-0121-3. Epub 2018 May 16.
6
Identification of serotonin 2A receptor as a novel HCV entry factor by a chemical biology strategy.
Protein Cell. 2019 Mar;10(3):178-195. doi: 10.1007/s13238-018-0521-z. Epub 2018 Mar 14.
8
A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.
J Antimicrob Chemother. 2017 Nov 1;72(11):2973-2989. doi: 10.1093/jac/dkx224.
9
Host-directed therapies for bacterial and viral infections.
Nat Rev Drug Discov. 2018 Jan;17(1):35-56. doi: 10.1038/nrd.2017.162. Epub 2017 Sep 22.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验